Copyright Reports & Markets. All rights reserved.

Global Hemostats and Tissue Sealants Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Hemostats and Tissue Sealants Market Overview

      • 1.1 Product Overview and Scope of Hemostats and Tissue Sealants
      • 1.2 Hemostats and Tissue Sealants Segment by Type
        • 1.2.1 Global Hemostats and Tissue Sealants Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Hemostats
        • 1.2.3 Tissue Sealants
      • 1.3 Hemostats and Tissue Sealants Segment by Application
        • 1.3.1 Hemostats and Tissue Sealants Consumption Comparison by Application (2014-2025)
        • 1.3.2 Clinical Medicine
        • 1.3.3 Scientific Research
      • 1.4 Global Hemostats and Tissue Sealants Market by Region
        • 1.4.1 Global Hemostats and Tissue Sealants Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Hemostats and Tissue Sealants Market Size
        • 1.5.1 Global Hemostats and Tissue Sealants Revenue (2014-2025)
        • 1.5.2 Global Hemostats and Tissue Sealants Production (2014-2025)

      2 Global Hemostats and Tissue Sealants Market Competition by Manufacturers

      • 2.1 Global Hemostats and Tissue Sealants Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Hemostats and Tissue Sealants Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Hemostats and Tissue Sealants Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Hemostats and Tissue Sealants Production Sites, Area Served, Product Types
      • 2.5 Hemostats and Tissue Sealants Market Competitive Situation and Trends
        • 2.5.1 Hemostats and Tissue Sealants Market Concentration Rate
        • 2.5.2 Hemostats and Tissue Sealants Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Hemostats and Tissue Sealants Production Market Share by Regions

      • 3.1 Global Hemostats and Tissue Sealants Production Market Share by Regions
      • 3.2 Global Hemostats and Tissue Sealants Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Hemostats and Tissue Sealants Production
        • 3.4.1 North America Hemostats and Tissue Sealants Production Growth Rate (2014-2019)
        • 3.4.2 North America Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Hemostats and Tissue Sealants Production
        • 3.5.1 Europe Hemostats and Tissue Sealants Production Growth Rate (2014-2019)
        • 3.5.2 Europe Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Hemostats and Tissue Sealants Production (2014-2019)
        • 3.6.1 China Hemostats and Tissue Sealants Production Growth Rate (2014-2019)
        • 3.6.2 China Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Hemostats and Tissue Sealants Production (2014-2019)
        • 3.7.1 Japan Hemostats and Tissue Sealants Production Growth Rate (2014-2019)
        • 3.7.2 Japan Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Hemostats and Tissue Sealants Consumption by Regions

      • 4.1 Global Hemostats and Tissue Sealants Consumption by Regions
      • 4.2 North America Hemostats and Tissue Sealants Consumption (2014-2019)
      • 4.3 Europe Hemostats and Tissue Sealants Consumption (2014-2019)
      • 4.4 China Hemostats and Tissue Sealants Consumption (2014-2019)
      • 4.5 Japan Hemostats and Tissue Sealants Consumption (2014-2019)

      5 Global Hemostats and Tissue Sealants Production, Revenue, Price Trend by Type

      • 5.1 Global Hemostats and Tissue Sealants Production Market Share by Type (2014-2019)
      • 5.2 Global Hemostats and Tissue Sealants Revenue Market Share by Type (2014-2019)
      • 5.3 Global Hemostats and Tissue Sealants Price by Type (2014-2019)
      • 5.4 Global Hemostats and Tissue Sealants Production Growth by Type (2014-2019)

      6 Global Hemostats and Tissue Sealants Market Analysis by Applications

      • 6.1 Global Hemostats and Tissue Sealants Consumption Market Share by Application (2014-2019)
      • 6.2 Global Hemostats and Tissue Sealants Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Hemostats and Tissue Sealants Business

      • 7.1 Baxter
        • 7.1.1 Baxter Hemostats and Tissue Sealants Production Sites and Area Served
        • 7.1.2 Hemostats and Tissue Sealants Product Introduction, Application and Specification
        • 7.1.3 Baxter Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 CR Bard
        • 7.2.1 CR Bard Hemostats and Tissue Sealants Production Sites and Area Served
        • 7.2.2 Hemostats and Tissue Sealants Product Introduction, Application and Specification
        • 7.2.3 CR Bard Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Johnson & Johnson
        • 7.3.1 Johnson & Johnson Hemostats and Tissue Sealants Production Sites and Area Served
        • 7.3.2 Hemostats and Tissue Sealants Product Introduction, Application and Specification
        • 7.3.3 Johnson & Johnson Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 B.Braun
        • 7.4.1 B.Braun Hemostats and Tissue Sealants Production Sites and Area Served
        • 7.4.2 Hemostats and Tissue Sealants Product Introduction, Application and Specification
        • 7.4.3 B.Braun Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Cardinal Health
        • 7.5.1 Cardinal Health Hemostats and Tissue Sealants Production Sites and Area Served
        • 7.5.2 Hemostats and Tissue Sealants Product Introduction, Application and Specification
        • 7.5.3 Cardinal Health Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Cryolife
        • 7.6.1 Cryolife Hemostats and Tissue Sealants Production Sites and Area Served
        • 7.6.2 Hemostats and Tissue Sealants Product Introduction, Application and Specification
        • 7.6.3 Cryolife Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Neomend
        • 7.7.1 Neomend Hemostats and Tissue Sealants Production Sites and Area Served
        • 7.7.2 Hemostats and Tissue Sealants Product Introduction, Application and Specification
        • 7.7.3 Neomend Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Vivostat
        • 7.8.1 Vivostat Hemostats and Tissue Sealants Production Sites and Area Served
        • 7.8.2 Hemostats and Tissue Sealants Product Introduction, Application and Specification
        • 7.8.3 Vivostat Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Z-Medica
        • 7.9.1 Z-Medica Hemostats and Tissue Sealants Production Sites and Area Served
        • 7.9.2 Hemostats and Tissue Sealants Product Introduction, Application and Specification
        • 7.9.3 Z-Medica Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served

      8 Hemostats and Tissue Sealants Manufacturing Cost Analysis

      • 8.1 Hemostats and Tissue Sealants Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Hemostats and Tissue Sealants
      • 8.4 Hemostats and Tissue Sealants Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Hemostats and Tissue Sealants Distributors List
      • 9.3 Hemostats and Tissue Sealants Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Hemostats and Tissue Sealants Market Forecast

      • 11.1 Global Hemostats and Tissue Sealants Production, Revenue Forecast
        • 11.1.1 Global Hemostats and Tissue Sealants Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Hemostats and Tissue Sealants Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Hemostats and Tissue Sealants Price and Trend Forecast (2019-2025)
      • 11.2 Global Hemostats and Tissue Sealants Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Hemostats and Tissue Sealants Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Hemostats and Tissue Sealants Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Hemostats and Tissue Sealants Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Hemostats and Tissue Sealants Production, Revenue Forecast (2019-2025)
      • 11.3 Global Hemostats and Tissue Sealants Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Hemostats and Tissue Sealants Consumption Forecast (2019-2025)
        • 11.3.2 Europe Hemostats and Tissue Sealants Consumption Forecast (2019-2025)
        • 11.3.3 China Hemostats and Tissue Sealants Consumption Forecast (2019-2025)
        • 11.3.4 Japan Hemostats and Tissue Sealants Consumption Forecast (2019-2025)
      • 11.4 Global Hemostats and Tissue Sealants Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Hemostats and Tissue Sealants Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Blood clotting or coagulation, is an important process that eliminates excessive bleeding when a blood vessel is damaged. Platelets and proteins work together to stop the bleeding by forming a clot over the injury. Blood clottage is one of the mechanisms that reduce the loss of blood from damaged blood vessels. Hemostats and tissue sealants are used post-surgery or traumatic injury to bind or hold external tissue (skin) as well as internal tissue (blood vessels). Some key types of hemostats and tissue sealants include fibrin sealants, collagen-based compounds, synthetic agents, and tissue adhesive glues such as hydrogels and glutaraldehyde glues. Fibrin sealants have a wide range of medical applications.
        The recent increase in number of out-patient surgeries is the prime driver for the growth of this market. Since these surgeries help to reduce the overall healthcare expenditure, they are increasingly being preferred by insurance payers to acquire reimbursements for their surgeries. Furthermore, as the out-patient surgeries do not require overnight stays, they are readily available to the patients.
        The increasing use of fibrin sealants for hemostats aids is an emerging trend in this market. The use of fibrin sealants helps in the rapid formation of a stable clot and can also be applied to small blood vessels and to the areas that are difficult to reach with conventional sutures. Since there is minimal blood loss involved in this process, the use of fibrin sealants will witness a rapid increase during the forecast period.

        The global Hemostats and Tissue Sealants market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Hemostats and Tissue Sealants volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hemostats and Tissue Sealants market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Baxter
        CR Bard
        Johnson & Johnson
        B.Braun
        Cardinal Health
        Cryolife
        Neomend
        Vivostat
        Z-Medica

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Hemostats
        Tissue Sealants

        Segment by Application
        Clinical Medicine
        Scientific Research

        Buy now